Showing 2411-2420 of 5771 results for "".
- VSP Global Announces Executive Team Appointmentshttps://modernod.com/news/vsp-global-announces-executive-team-appointments/2479797/VSP Global announced the appointments of Earnie Franklin as chief technology officer (CTO), and Alec Mahmood as chief financial officer (CFO). Mr. Franklin and Mr. Mahmood will report to Michael Guyette, VSP Global’s president and CEO. “I am thrilled to welcome these two phenomenal l
- Staar Surgical Announces Agreement with Dr. Tobias Neuhann in Germany to Create Collaboration with Single Site Ophthalmology Clinicshttps://modernod.com/news/staar-surgical-announces-agreement-with-dr-tobias-neuhann-in-germany-to-create-collaboration-with-single-site-ophthalmology-clinics/2479798/Staar Surgical announced a multi-year strategic alliance agreement with Tobias Neuhann, MD, of the Augenklinik am Marienplatz (Eye Clinic at Marienplatz) in Munich, Germany. The agreement serves as a global partnership model for smaller and single site refractive surgery eye clinics that aim to p
- Sensimed Announces Approval of the Sensimed Triggerfish in Japanhttps://modernod.com/news/sensimed-announces-approval-of-the-sensimed-triggerfish-in-japan/2479800/Sensimed has announced the registration of the Sensimed Triggerfish sensor and monitoring system as a medical device in Japan. The Japanese partner and distributor of Sensimed, SEED Co., h
- Kala Pharmaceuticals Announces Financing from Athyrium Capital Management Totaling $110 Millionhttps://modernod.com/news/kala-pharmaceuticals-announces-financing-from-athyrium-capital-management-totaling-110-million/2479817/Kala Pharmaceuticals announced the closing of Kala’s $110 million credit facility with funds managed by Athyrium Capital Management LP, a healthcare focused investment firm. “We are pleased to be partnering with Athyrium and to have their support and confidence in Inveltys for the treatmen
- EyePoint Pharmaceuticals Announces Proceeds of $28.9 Million from Exercised Warrantshttps://modernod.com/news/eyepoint-pharmaceuticals-announces-proceeds-of-28-9-million-from-exercised-warrants/2479829/EyePoint Pharmaceuticals announced that the company has received proceeds of $28.9 million from the exercise of warrants by EW Healthcare Partners, Rosalind Advisors, and another accredited investor (Second Tranche Investors). “We are pleased to receive the continued support of EW Healthc
- Omeros Announces Reinstatement of Pass-Through Status for Omidriahttps://modernod.com/news/omeros-announces-reinstatement-of-pass-through-status-for-omidria/2479831/Omeros announced reinstatement of separate payment by the Centers for Medicare and Medicaid Services (CMS) under the pass-through program for Omidria (phenylephrine and ketorolac intraocular solution) 1%/0.3%. The pass-through status is effective as of October 1, 2018.
- PeptiDream Announces Drug Discovery and Development Agreement with Santen Pharmaceuticalhttps://modernod.com/news/peptidream-announces-drug-discovery-and-development-agreement-with-santen-pharmaceutical/2479839/PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company, announced that it has entered into a broad-based multi-target discovery and development agreement with Osaka-based Santen Pharmaceuticals. Under the agreement, PeptiDream will use its proprietary Peptide Discovery Platform
- Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trialhttps://modernod.com/news/aldeyra-therapeutics-announces-positive-results-from-phase-2b-dry-eye-disease-clinical-trial/2479841/Aldeyra Therapeutics announced positive results from its phase 2b clinical trial of topical ocular reproxalap in patients with dry eye disease. “The early onset and broad activity observed in the phase 2b clinical trial sugg
- National Industries for the Blind Announces New Strategic Alliancehttps://modernod.com/news/national-industries-for-the-blind-announces-new-strategic-alliance/2479842/National Industries for the Blind (NIB) announced a new strategic alliance with the William L. Hudson BVI Workforce Innovation Center to deliver world-class training and professional development for people who are blind. The William L. Hudson BVI Workforce Innovation Center, located in
- Heidelberg Engineering Announces CE Mark Approval of Anterionhttps://modernod.com/news/heidelberg-engineering-announces-the-ce-marking-of-anterion/2479854/Heidelberg Engineering announced the CE-marking of Anterion, a platform designed to transform anterior segment diagnostics and workflow. The new Anterion provides anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solutio